1 January 2021 in BioMed Research International
Background. It has been reported that patients with inflammatory bowel disease (IBD) are more susceptible to periodontitis. However, data regarding the risk of periodontitis in IBD patients are scarce, and results from individual studies remain controversial. The aim of this study is to investigate the risk of periodontitis in IBD patients. Methods. Web of Science, PubMed, and Embase were searched for studies investigating the risk of periodontitis in the IBD patient population from Jan. 2000 to Nov. 2020. Articles were included if they contained the number of people with IBD diagnosed with periodontitis (or periodontal disease parameters) compared with a control group. Case reports, reviews, animal studies, and articles without available abstracts were excluded. A pooled odds ratio (OR) and 95% confidence interval (CI) were calculated to assess the association between periodontitis and IBD. Results. Six studies were included in the meta‐analysis. The overall risk of periodontitis was significantly higher in IBD patients than controls (OR: 2.10, 95% CI: 1.60‐2.74; I2 = 27%). In particular, Crohn’s disease (CD) and ulcerative colitis (UC) were both linked to an increased risk of periodontitis (OR: 1.72, 95% CI: 1.36‐2.19; I2 = 0% for CD vs. OR:2.39, 95% CI: 1.19‐4.80; I2 = 85% for UC). Conclusions. IBD patients are at higher risk of periodontitis than controls. After subgroup analysis, the elevated risk remained significant when analyzing CD or UC alone. UC patients were at higher risk of developing periodontitis than CD patients.
26 May 2022 in International Journal of Biological Macromolecules
24 March 2023 in Acta Biomaterialia
19 March 2024 in Chemical Society Reviews
This review provides a comprehensive overview of the latest nanochemistry advancements in the design, synthesis, and utilization of engineered gold nanostructures (GNSs) for dental healthcare applications.
23 November 2022 in Materials Science and Engineering: C
24 November 2025 in Journal of Clinical Periodontology
Aim: To investigate the association between tryptophan‐derived microbial metabolites and periodontitis, and to assess whether the differential tryptophan metabolite indole‐3‐acetic acid (IAA) could ameliorate periodontitis and elucidate its potential mechanism. Materials and Methods: The association between tryptophan‐derived metabolites and periodontitis was evaluated using targeted metabolomics analysis, 16S rRNA gene amplicon sequencing and correlation analysis. The impact of the differential metabolite IAA on periodontitis was assessed with micro‐computed tomography (micro‐CT), histological staining and real‐time quantitative polymerase chain reaction (RT‐qPCR). The effects of IAA on macrophages under an inflammatory microenvironment, along with its potential mechanism, were explored using RT‐qPCR, enzyme‐linked immunosorbent assay (ELISA), immunofluorescence staining and Western blot. Results: IAA, a differential tryptophan metabolite, was identified in the saliva of patients with periodontitis and periodontally healthy individuals. Local application of IAA in experimental mice with periodontitis alleviated the immune‐inflammatory response and reduced periodontal tissue destruction. Mechanistically, IAA induced M2 macrophage polarisation by activating the AhR/CYP1A1 axis, thereby contributing to the amelioration of periodontal destruction. Conclusions: These findings highlight the potential role of the microbial metabolite IAA in the development and treatment of periodontitis, offering a new perspective for intervention strategies based on microbial metabolites for periodontitis.